MindWalk Holdings (HYFT) Shares Outstanding (Weighted Average) (2020 - 2026)
MindWalk Holdings (HYFT) reported Shares Outstanding (Weighted Average) of $98.9 million for Q1 2026, up 13904775.82% year-over-year from N/an in Q1 2025, and up 85771207.86% quarter-over-quarter from $115.34 in Q4 2025.
MindWalk Holdings (HYFT) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $98.9 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $98.9 million, up 13904775.82% year-over-year; the trailing twelve-month figure through Jan 2026 was $98.9 million (up 13904775.82% YoY), and the FY2025 annual result was $97.9 million, up 417.8% from the prior year.
- Shares Outstanding (Weighted Average) improved to $98.9 million in Q1 2026 per HYFT's latest filing, from $115.34 in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $98.9 million in Q1 2026 and troughed at $115.34 in Q4 2025.
- A 5-year average of $24.0 million and a median of $18.8 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Weighted Average) tumbled 100.0% in 2023, then soared 13904775.82% in 2026.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $504.44 in 2022, then tumbled by 63.45% to $184.37 in 2023, then grew by 11.21% to $205.04 in 2024, then sank by 43.75% to $115.34 in 2025, then surged by 85771207.86% to $98.9 million in 2026.
- Business Quant data shows HYFT's Shares Outstanding (Weighted Average) at $98.9 million in Q1 2026, $115.34 in Q4 2025, and $33.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 185,491.37 Bn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 400.00 Bn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 100.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 417.01 Bn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 68.88 Bn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 254.10 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 928.40 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 98.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 98.93 Mn |
| Oct 31, 2025 | 115.34 |
| Jul 31, 2025 | 33.59 Mn |
| Apr 30, 2025 | 95.83 Mn |
| Jan 31, 2025 | 711.47 |
| Oct 31, 2024 | 205.04 |
| Jul 31, 2024 | 19.82 Mn |
| Apr 30, 2024 | 18.91 Mn |
| Jan 31, 2024 | 251.51 |
| Oct 31, 2023 | 184.37 |
| Jul 31, 2023 | 18.77 Mn |
| Apr 30, 2023 | 18.40 Mn |
| Jan 31, 2023 | 637.60 |
| Oct 31, 2022 | 504.44 |
| Jul 31, 2022 | 19.24 Mn |
| Apr 30, 2022 | 19.33 Mn |
| Jan 31, 2022 | 64.62 Mn |
| Oct 31, 2021 | 15.39 Mn |
| Jul 31, 2021 | 15.65 Mn |
| Apr 30, 2021 | 15.23 Mn |